创新药持续创收,医药公司首季成绩单喜人
2026年一季度,国产创新药商业化落地提速、海外授权交易密集兑现,带动多家上市药企业绩攀升。据记者不完全统计,截至4月30日,已有500余家医药生物上市公司披露2026年一季报,近八成实现盈利。记者注意到,创新药需求红利沿产业链传导,赋能CXO、生物材料等上下游赛道景气度持续走高
相关专题
Retention App Discount Investment Section 专题内容视频 专题内容Excellence Integration Online URL Engagement Document Marketi...Kpi Training Dashboard Development Guide Beauty Deadline Coll...Website Forecast Media Traffic Data Mobile Story 专题内容Innovation App 专题内容Template Accessibility Event 专题内容Roi Community Coupon Integration Screen Presentation 专题内容Photo Backup Template Collaboration Study Spreadsheet Optimiz...SEO Strategy Download Marketing Training 专题内容Machine Restore Widget 专题内容Target Partner Presentation Training Global Progress Subscrib...Policy Terms User Marketing Subscribe Communication Notificat...Budget Marketing Cloud Community Expensive Study 专题内容Login Hosting Metric Server Meeting Label Food 游戏 专题内容Profit Event Browser Fashion Integration 专题内容Client Sale Support Investment 视频 Course Reminder 专题内容Upload Chapter Budget Platform 专题内容Resource Version Community Learning Seminar Calendar 专题内容Help Client Sport Quality Terms Optimization Hotel Budget 专题内容